10-Q: Upexi, Inc. Q3 2026 10-Q Filing Analysis
Quarterly Report
Upexi, Inc. reports significant shift to digital assets, with substantial unrealized losses and increased digital asset revenue, while traditional product revenue declines.
Summary
- Upexi, Inc. has transitioned its primary focus to a digital asset treasury strategy, heavily invested in Solana (SOL) tokens, while divesting from legacy consumer product lines.
- The company reported a significant increase in digital asset revenue to $3.5 million for the three months ended March 31, 2026, compared to zero in the prior year period.
- However, this shift is accompanied by substantial unrealized losses on digital assets, amounting to $92.3 million for the quarter and $178.8 million for the nine months ended March 31, 2026.
- Traditional product revenue saw a sharp decline of 66.8% year-over-year for the quarter, reflecting the strategic exit from manufacturing and distribution operations.
- General and administrative expenses increased significantly due to costs associated with the digital asset strategy, including public company expenses, professional fees, treasury fees, and employee compensation.
- The company reported a net loss of $109.3 million for the quarter and $221.5 million for the nine months ended March 31, 2026.
- Despite the net loss, the company has a positive working capital of $50.9 million as of March 31, 2026, and believes it has sufficient working capital for the next twelve months.
- Material weaknesses in internal controls over financial reporting were identified, including inadequate segregation of duties and lack of multiple levels of supervision, with plans for remediation by the end of fiscal year 2026.
- Several legal proceedings are ongoing, including arbitration with GSR Strategies LLC and a fraud, misrepresentation, and breach of contract lawsuit from Bloomios, Inc., Infused Confections, LLC, and Infusionz, LLC.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as negative due to substantial unrealized losses on digital assets, a significant net loss, and material weaknesses in internal controls, despite positive developments in digital asset revenue and working capital.
Positives
- Digital asset revenue increased significantly to $3.5 million for the three months ended March 31, 2026, from zero in the prior year, indicating successful execution of the new strategy.
- The company has a positive working capital of $50.9 million as of March 31, 2026, up from $24.2 million in the prior year.
- Gross margin improved significantly to 80.4% for the quarter ended March 31, 2026, from 49.3% in the prior year, driven by the exit from lower-margin manufacturing operations.
- The company believes it has sufficient working capital to fund operations for the next twelve months.
- The company was successful in obtaining the dismissal of individual Board members from the Bloomios lawsuit and filed counterclaims for approximately $19.5 million owed.
- Cygnet Online, LLC, a subsidiary, was awarded approximately $0.4 million in damages in an arbitration case against Get Fit Fast Supplements, LLC.
Negatives
- Substantial unrealized losses on digital assets totaling $92.3 million for the quarter and $178.8 million for the nine months ended March 31, 2026.
- Significant decline in traditional product revenue by 66.8% for the quarter, reflecting the strategic shift away from these lines.
- Net loss of $109.3 million for the quarter and $221.5 million for the nine months ended March 31, 2026.
- Material weaknesses in internal controls over financial reporting were identified, including inadequate segregation of duties and lack of supervision.
- Increased general and administrative expenses by 86.6% for the quarter and 254.6% for the nine months, largely due to costs associated with the digital asset strategy.
- Significant increase in 'Other operating expenses' by $18.7 million for the nine months, primarily due to stock-based compensation and digital asset service fees.
- The company has a substantial amount of convertible notes payable ($181 million) which carry conversion prices that could lead to significant dilution if converted.
Risks
- The company holds a significant portion of its assets in cryptocurrencies (Solana tokens), which are subject to substantial market volatility, evolving regulatory frameworks, liquidity constraints, cybersecurity threats, and technological risks.
- The value of the company's digital assets can fluctuate significantly, impacting its financial condition and results of operations.
- The company has identified material weaknesses in its internal controls over financial reporting, which could lead to misstatements in financial reporting.
- Ongoing legal proceedings, including arbitration and lawsuits, could result in significant financial liabilities or reputational damage.
- The company's convertible notes are convertible into common stock at prices significantly lower than the current market price, posing a risk of substantial dilution.
- The company has a substantial amount of debt, including short-term treasury debt and convertible notes, which could impact its financial flexibility.
Future Outlook
The company expects digital asset revenue to increase as its Solana token holdings and staking activities grow. Management anticipates a significant decline in sales and marketing expenses quarter-over-quarter for the remainder of the year due to reduced spending on legacy products and elimination of fixed expenses. The company also expects distribution costs to continue declining. However, general and administrative expenses are expected to remain elevated due to the ongoing digital asset strategy. The company has a shelf registration statement on file with the SEC, indicating potential future capital raises for corporate purposes.
Management Comments
- Management's focus is on the digital asset strategy, and resources are allocated accordingly.
- We do not expect significant increases to traditional product revenue sources in future quarters.
- The digital asset revenue is expected to increase as the number of SOL tokens the Company has staked increases, the overall increase in the price of SOL and the Company's continued expansion of its digital asset strategy.
- Management expects the sales and marketing expenses to significantly decline, quarter over quarter for the remainder of the year as less marketing expenses are spent on the remaining products and several of the fixed sales and marketing expenses have been eliminated.
- The Company believes it will have sufficient working capital to fund its operations over the twelve months following the date of the issuance of these condensed consolidated financial statements and meet all of its debt obligations.
Industry Context
StockSavvy.ai notes that Upexi's strategic pivot to a digital asset treasury, specifically focusing on Solana, aligns with a broader trend of companies exploring cryptocurrencies for yield generation and treasury management. However, the significant unrealized losses highlight the inherent volatility and risks associated with this asset class, a challenge faced by many firms venturing into digital assets.
Comparison to Industry Standards
- Companies like MicroStrategy and Tesla have also invested heavily in Bitcoin as a treasury reserve asset, demonstrating a trend of corporate adoption of cryptocurrencies. However, Upexi's focus on Solana, a less established asset than Bitcoin, presents a different risk-reward profile.
- The staking revenue model is common in the Proof-of-Stake cryptocurrency ecosystem, with many DeFi protocols and validators offering similar yield opportunities. Upexi's reported digital asset revenue of $3.5 million for the quarter is a notable figure for a company of its size in this space.
- The significant unrealized losses on digital assets are a common occurrence for companies holding volatile cryptocurrencies, especially during periods of market downturns. The magnitude of Upexi's losses ($92.3 million in the quarter) is substantial relative to its overall asset base, indicating a high degree of risk exposure.
- The company's struggle with material weaknesses in internal controls is not uncommon for rapidly growing companies, particularly those undergoing significant strategic shifts. However, robust internal controls are a standard expectation for publicly traded companies, and failure to remediate these weaknesses can lead to increased scrutiny from regulators and investors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Controls | Material weaknesses identified in internal controls over financial reporting, including inadequate segregation of duties and lack of multiple levels of supervision and review. | March 31, 2026 | Reasonable possibility of material misstatement in financial statements not being prevented or detected on a timely basis. Remediation planned by end of fiscal year 2026. |
| Disclosure Controls and Procedures | Disclosure controls and procedures were not effective as of March 31, 2026. | March 31, 2026 | Information may not be recorded, processed, summarized, and reported within required time periods, and may not be communicated appropriately for timely disclosure decisions. |
Legal Proceedings
- Upexi, Inc. v. GSR Strategies LLC: Arbitration concerning an Asset Management Agreement, with Upexi seeking damages and declaratory judgments, and GSR asserting counterclaims.
- Bloomios, Inc., Infused Confections, LLC and Infusionz, LLC v. Upexi, Inc.: Lawsuit alleging fraud, misrepresentation, and breach of contract related to a prior acquisition. Upexi has filed counterclaims for approximately $19.5 million owed.
- MVW Holdings v. E-Core Technology, Inc. and Upexi, Inc.: Trade-dress lawsuit involving products sold by E-Core Technology, Inc. The case is in the fact-discovery phase.
- Eric Hanig v. Upexi, Inc. and Cygnet Online, LLC: Lawsuit for alleged failure to pay $300,000. Upexi denies claims and has filed counterclaims for fraudulent inducement and misappropriation.
- Get Fit Fast Supplements, LLC v. Cygnet Online, LLC, et al.: Arbitration case related to breach of contract and fraud claims associated with prior acquisitions. Cygnet was awarded approximately $0.4 million in damages.
Related Party Transactions
- In March 2025, Allan Marshall purchased 125,000 shares of Series A preferred stock for $2.60 per share, settled through the cancellation of a $400,000 related party advance.
- The Company leased approximately 10,000 square feet of warehouse and office space from MFA 2510 Merchant LLC, owned by CEO Allan Marshall, for $20,060 per month. This lease was terminated as of March 31, 2026.
- Allan Marshall, CEO, is one of the minority interest buyers in the sale of VitaMedica, Inc. for $6,000,000.
Stakeholder Impact
- Shareholders: Potential for significant dilution due to convertible notes with low conversion prices. Volatility of digital assets impacts overall company value. Material weaknesses in internal controls raise concerns about financial reporting reliability.
- Employees: Increased compensation expenses related to stock-based awards and the Phantom Stock Appreciation Plan. Potential impact from the exit of manufacturing and distribution operations.
- Creditors: The company has substantial debt, including short-term treasury debt and convertible notes, which could affect its ability to meet obligations.
- Suppliers: The exit from certain manufacturing and distribution operations may impact suppliers in those specific segments.
Next Steps
- Remediate material weaknesses in internal controls over financial reporting by the end of fiscal year 2026.
- Continue to execute the digital asset treasury strategy, focusing on Solana tokens and staking.
- Monitor and manage the volatility and risks associated with digital asset holdings.
- Potentially utilize the shelf registration statement for future capital raises.
- Continue to defend against ongoing legal proceedings and pursue counterclaims.
Key Dates
| Date | Description |
|---|---|
| 2024-06-13 | Company entered into a Stock Purchase Agreement to sell 100% of VitaMedica, Inc. |
| 2024-07-01 | Start of fiscal year for which ASU 2023-08 was adopted early. |
| 2024-10-03 | Effective date of the 1-for-20 reverse stock split. |
| 2024-10-08 | Additional issuance of shares for round up of fractional shares post reverse stock split. |
| 2024-10-23 | Issuance of shares for round up of fractional shares post reverse stock split. |
| 2024-10-30 | Notification that shares issued for round up of fractional shares were returned to transfer agent. |
| 2024-12-20 | MVW Holdings filed a lawsuit against E-Core Technology, Inc. and Upexi, Inc. |
| 2025-01-01 | Start of fiscal year for which ASU 2023-09 is effective. |
| 2025-01-09 | Company entered into a securities purchase agreement for a secured convertible note. |
| 2025-03-01 | Date related to Series A preferred shares purchase by Allan Marshall. |
| 2025-03-28 | Date related to lease agreement with MFA Two Five One Zero Merchant LLC. |
| 2025-04-01 | Company entered into a lease agreement with MFA 2510 Merchant LLC. |
| 2025-04-01 | Start of fiscal year for which ASU 2023-08 was adopted. |
| 2025-04-07 | Bloomios, Inc., Infused Confections, LLC and Infusionz, LLC filed an action against the Company. |
| 2025-04-24 | Date related to exercise of pre-funded warrants. |
| 2025-06-30 | End of fiscal year 2025. |
| 2025-07-01 | Company approved the Upexi, Inc. Phantom Stock Appreciation Plan. |
| 2025-07-16 | Company entered into securities purchase agreements for secured convertible notes. |
| 2025-09-18 | Company filed a Certificate of Change to effect a reverse stock split. |
| 2025-11-03 | Date related to November 2025 private placement. |
| 2025-12-01 | Date related to Promissory Notes maturity. |
| 2025-12-26 | GSR Strategies LLC terminated the Asset Management Agreement. |
| 2026-01-01 | Start of fiscal year for which ASU 2024-03 is effective. |
| 2026-01-08 | Company's shelf registration statement declared effective. |
| 2026-01-09 | Company issued a secured convertible note. |
| 2026-02-01 | Date related to February 2026 private placement. |
| 2026-02-28 | Date related to February 2026 private placement. |
| 2026-03-31 | End of the quarterly period. |
| 2026-04-01 | Company no longer leases the facility at MFA 2510 Merchant LLC. |
| 2026-05-11 | Date as of which the number of shares outstanding is reported. |
| 2026-05-12 | Date of the report and certifications. |
| 2027-01-09 | Maturity date for Convertible Note - January 2026 Issuance. |
| 2027-07-16 | Maturity date for Convertible Notes - July 2025 Issuance. |
| 2027-12-31 | Date related to BitGo Credit Facility. |
| 2028-01-09 | Maturity date for Convertible Note - January 2026 Issuance. |
| 2051-10-06 | Maturity date for SBA note payable. |
Recommendation
holdWhile Upexi is making a strategic pivot towards digital assets with potential for high returns, the significant unrealized losses, substantial net loss, and material weaknesses in internal controls present considerable risks. The company's ability to manage digital asset volatility and remediate control deficiencies will be critical. The current situation warrants a 'hold' recommendation, pending further clarity on the execution of its digital asset strategy and improvement in financial reporting controls.
Keywords
Upexi, UPXI, 10-Q, SEC Filing, Digital Assets, Solana, Cryptocurrency, Treasury Strategy, Financial Report, Quarterly Results, Unrealized Loss, Stock-Based Compensation, Convertible Notes, Internal Controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.